CIK 0001062822
- Non-accelerated filer
- Smaller reporting company
LEXICON PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- LXRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 760474169
- Phone
- +1 281-863-3000
- Business address
- 2445 TECHNOLOGY FOREST BLVD., SUITE 1100, THE WOODLANDS, TX, 77381
- Former names
- LEXICON PHARMACEUTICALS, INC./DE, LEXICON GENETICS INC/TX
- Open-market buys, last 90 days
- $49,999
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$49,999. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-02-07 | WADE JEFFREY L EVP, Corp Adm Affairs and CFO | Grant or award · Stock Option (Right to Buy) | +140,900 | 140,900 | ||
| 2019-02-07 | WADE JEFFREY L EVP, Corp Adm Affairs and CFO | Grant or award · Restricted Stock Units | +75,870 | 75,870 | ||
| 2019-02-07 | COATS LONNEL President and CEO | Grant or award · Stock Option (Right to Buy) | +442,260 | 442,260 | ||
| 2019-02-07 | COATS LONNEL President and CEO | Grant or award · Restricted Stock Units | +238,140 | 238,140 | ||
| 2018-06-28 | Invus Public Equities, L.P. Director | Purchase | +57,724 | $12.45 | $719K | 3,516,214 |
| 2018-06-27 | Invus Public Equities, L.P. Director | Purchase | +125,114 | $12.54 | $1.6M | 3,458,490 |
| 2018-06-25 | Invus Public Equities, L.P. Director | Purchase | +228,264 | $12.95 | $3.0M | 3,333,376 |
| 2018-06-22 | Invus Public Equities, L.P. Director | Purchase | +25,461 | $13.36 | $340K | 3,105,112 |
| 2018-06-21 | Invus Public Equities, L.P. Director | Purchase | +51,600 | $13.27 | $685K | 3,079,651 |
| 2018-06-20 | Invus Public Equities, L.P. Director | Purchase | +12,391 | $13.28 | $165K | 3,028,051 |
| 2018-06-19 | Invus Public Equities, L.P. Director | Purchase | +8,982 | $13.45 | $121K | 3,015,660 |
| 2018-06-18 | Invus Public Equities, L.P. Director | Purchase | +36,584 | $13.06 | $478K | 3,006,678 |
| 2018-06-14 | Invus Public Equities, L.P. Director | Purchase | +9,200 | $12.66 | $116K | 2,970,094 |
| 2018-06-12 | Invus Public Equities, L.P. Director | Purchase | +107,023 | $12.83 | $1.4M | 2,960,894 |
| 2018-06-11 | Invus Public Equities, L.P. Director | Purchase | +98,626 | $12.75 | $1.3M | 2,853,871 |
| 2018-06-08 | Tessmer James F VP, Finance & Accounting | Exercise or conversion | +10,000 | $10.15 | $102K | 35,643 |
| 2018-06-08 | Tessmer James F VP, Finance & Accounting | Sale | −10,000 | $12.91 | $129K | 25,643 |
| 2018-06-08 | Tessmer James F VP, Finance & Accounting | Exercise or conversion · Stock Option (Right to Buy) | −10,000 | 11,428 | ||
| 2018-06-08 | Invus Public Equities, L.P. Director | Purchase | +29,747 | $12.89 | $383K | 2,755,245 |
| 2018-06-07 | Invus Public Equities, L.P. Director | Purchase | +57,439 | $12.93 | $743K | 2,725,498 |
Page 49 of 51 · 1,001 trades